Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 5099

1.

[A comparative study of different types of pharmacotherapy in treatment of depressive phase of bipolar II disorder].

Ushkalova AV, Kostiukova EG, Mosolov SN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(1 Vypusk 2 Depressiia):23-30. Russian.

PMID:
25909803
2.

Internet-Based Cognitive Behavioral Therapy for Residual Symptoms in Bipolar Disorder Type II: A Single-Subject Design Pilot Study.

Holländare F, Eriksson A, Lövgren L, Humble MB, Boersma K.

JMIR Res Protoc. 2015 Apr 23;4(2):e44. doi: 10.2196/resprot.3910.

PMID:
25908235
3.

Cognitive Styles in Mood Disorders: Discriminative Ability of Unipolar and Bipolar Cognitive Profiles.

Shapero BG, Stange JP, Goldstein KE, Black CL, Molz AR, Hamlat EJ, Black SK, Boccia AS, Abramson LY, Alloy LB.

Int J Cogn Ther. 2015 Mar;8(1):35-60.

4.

Hamilton depression rating scale and montgomery-asberg depression rating scale in depressed and bipolar I patients: psychometric properties in a Brazilian sample.

Carneiro AM, Fernandes F, Moreno RA.

Health Qual Life Outcomes. 2015 Apr 2;13(1):42. doi: 10.1186/s12955-015-0235-3.

5.

Validation of life-charts documented with the personal life-chart app - a self-monitoring tool for bipolar disorder.

Schärer LO, Krienke UJ, Graf SM, Meltzer K, Langosch JM.

BMC Psychiatry. 2015 Mar 14;15:49. doi: 10.1186/s12888-015-0414-0.

6.

Vagus nerve stimulation for treatment-resistant mood disorders: a long-term naturalistic study.

Albert U, Maina G, Aguglia A, Vitalucci A, Bogetto F, Fronda C, Ducati A, Lanotte M.

BMC Psychiatry. 2015 Mar 31;15:64. doi: 10.1186/s12888-015-0435-8.

7.

A 13-Week, Randomized Double-Blind, Placebo-Controlled, Cross-Over Trial of Ziprasidone in Bipolar Spectrum Disorder.

Patkar AA, Pae CU, Vöhringer PA, Mauer S, Narasimhan M, Dalley S, Loebel A, Masand PS, Nassir Ghaemi S.

J Clin Psychopharmacol. 2015 Apr 16. [Epub ahead of print]

PMID:
25882763
8.

The relationship of Theory of Mind with symptoms and cognitive impairment in bipolar disorder: A prospective study.

Ioannidi N, Konstantakopoulos G, Sakkas D, Oulis P.

Psychiatriki. 2015 Jan-Mar;26(1):17-27.

PMID:
25880380
9.

From DSM-I to DSM-5.

Kontaxakis V, Konstantakopoulos G.

Psychiatriki. 2015 Jan-Mar;26(1):13-6. English, Greek, Modern.

PMID:
25880379
10.

The use of complementary and alternative medicine in adults with depressive disorders. A critical integrative review.

Solomon D, Adams J.

J Affect Disord. 2015 Mar 28;179:101-113. doi: 10.1016/j.jad.2015.03.031. [Epub ahead of print] Review.

PMID:
25863008
11.

Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial.

McIntyre RS, Cucchiaro J, Pikalov A, Kroger H, Loebel A.

J Clin Psychiatry. 2015 Mar 3. [Epub ahead of print]

12.

Who will benefit from antidepressants in the acute treatment of bipolar depression? A reanalysis of the STEP-BD study by Sachs et al. 2007, using Q-learning.

Wu F, Laber EB, Lipkovich IA, Severus E.

Int J Bipolar Disord. 2015 Apr 3;3:7. doi: 10.1186/s40345-014-0018-5. eCollection 2015.

13.

Collaborative care for patients with bipolar disorder: Effects on functioning and quality of life.

van der Voort TY, van Meijel B, Hoogendoorn AW, Goossens PJ, Beekman AT, Kupka RW.

J Affect Disord. 2015 Mar 11;179:14-22. doi: 10.1016/j.jad.2015.03.005. [Epub ahead of print]

PMID:
25841077
14.

Resting respiratory sinus arrhythmia is related to longer hospitalization in mood-disordered repetitive suicide attempters.

Lin Y, Lin C, Sun IW, Hsu CC, Fang CK, Lo MT, Huang HC, Liu SI.

World J Biol Psychiatry. 2015 Apr 3:1-11. [Epub ahead of print]

PMID:
25839729
15.

Autistic-like traits in adult patients with mood disorders and schizophrenia.

Matsuo J, Kamio Y, Takahashi H, Ota M, Teraishi T, Hori H, Nagashima A, Takei R, Higuchi T, Motohashi N, Kunugi H.

PLoS One. 2015 Apr 2;10(4):e0122711. doi: 10.1371/journal.pone.0122711. eCollection 2015.

16.

Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study.

Perugi G, Angst J, Azorin JM, Bowden CL, Mosolov S, Reis J, Vieta E, Young AH; BRIDGE-II-Mix Study Group.

J Clin Psychiatry. 2015 Mar;76(3):e351-8. doi: 10.4088/JCP.14m09092.

PMID:
25830457
17.

Electrophysiological evidence of a typical cognitive distortion in bipolar disorder.

Kopf J, Volkert J, Heidler S, Dresler T, Kittel-Schneider S, Gessner A, Herrmann MJ, Ehlis AC, Reif A.

Cortex. 2015 May;66:103-14. doi: 10.1016/j.cortex.2015.02.009. Epub 2015 Mar 5.

PMID:
25824981
18.

DSR-98776, a novel selective mGlu5 receptor negative allosteric modulator with potent antidepressant and antimanic activity.

Kato T, Takata M, Kitaichi M, Kassai M, Inoue M, Ishikawa C, Hirose W, Yoshida K, Shimizu I.

Eur J Pharmacol. 2015 Mar 28;757:11-20. doi: 10.1016/j.ejphar.2015.03.024. [Epub ahead of print]

PMID:
25823809
19.

Prolonged mania in a case of bipolar affective disorder.

Muneer A.

J Pak Med Assoc. 2014 Oct;64(10):1198-200.

PMID:
25823166
20.

Shared dimensions of performance and activation dysfunction in cognitive control in females with mood disorders.

Ryan KA, Dawson EL, Kassel MT, Weldon AL, Marshall DF, Meyers KK, Gabriel LB, Vederman AC, Weisenbach SL, McInnis MG, Zubieta JK, Langenecker SA.

Brain. 2015 May;138(Pt 5):1424-34. doi: 10.1093/brain/awv070. Epub 2015 Mar 28.

PMID:
25818869
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk